Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Scopolamine gel available in U.S. for motion sickness

April 26, 1996

U.S. government claims new antipsychotic compositions

April 26, 1996

Prograf approved for new indication in Japan, launched in France

April 26, 1996

MitoExtra enters clinical trials

April 26, 1996

Hyal-CT1101 effective in phase III trial

April 26, 1996

FDA approves Prilosec + Biaxin combination for H. pylori

April 19, 1996

Zanidip approved for marketing in U.K.

April 19, 1996

FDA approves new indication for Pravachol

April 19, 1996

Vaqta gets the green light from FDA

April 12, 1996

Improved Havrix approved by FDA

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...